Page last updated: 2024-10-23

aspirin and Nasopharyngeal Carcinoma

aspirin has been researched along with Nasopharyngeal Carcinoma in 3 studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Nasopharyngeal Carcinoma: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.

Research Excerpts

ExcerptRelevanceReference
"Regular aspirin use has been associated to decreased risk of several cancers, but evidence on nasopharyngeal carcinoma is scanty."3.81Regular aspirin use and nasopharyngeal cancer risk: A case-control study in Italy. ( Bosetti, C; Di Maso, M; Garavello, W; La Vecchia, C; Libra, M; Montella, M; Polesel, J; Serraino, D, 2015)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chang, H1
Tao, YL1
Ye, WJ1
Xiao, WW1
Xia, YF1
Gao, YH1
Xiao, X1
Zhang, Z1
Chang, ET1
Liu, Z1
Liu, Q1
Cai, Y1
Chen, G1
Huang, QH1
Xie, SH1
Cao, SM1
Shao, JY1
Jia, WH1
Zheng, Y1
Liao, J1
Chen, Y1
Lin, L1
Ernberg, I1
Huang, G1
Zeng, Y1
Zeng, YX1
Adami, HO1
Ye, W1
Di Maso, M1
Bosetti, C1
La Vecchia, C1
Garavello, W1
Montella, M1
Libra, M1
Serraino, D1
Polesel, J1

Other Studies

3 other studies available for aspirin and Nasopharyngeal Carcinoma

ArticleYear
Regular aspirin intake and prognosis of TxN2-3M0 nasopharyngeal carcinoma: A cohort study based on propensity score matching.
    Oral oncology, 2020, Volume: 103

    Topics: Adolescent; Adult; Aged; Aspirin; Child; Disease-Free Survival; Female; Humans; Male; Middle Aged; M

2020
Medical History, Medication Use, and Risk of Nasopharyngeal Carcinoma.
    American journal of epidemiology, 2018, 10-01, Volume: 187, Issue:10

    Topics: Adult; Aged; Aspirin; Case-Control Studies; China; Chronic Disease; Female; Humans; Logistic Models;

2018
Regular aspirin use and nasopharyngeal cancer risk: A case-control study in Italy.
    Cancer epidemiology, 2015, Volume: 39, Issue:4

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma; Case-Control Studies; Fema

2015